Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study

This study was conducted to investigate the effects of long-term low-dose lithium adjunct to antipsychotic agent use on the cognitive performance, whole-brain gray-matter volume (GMV), and interleukin-6 (IL-6) level in drug-naive patients with first-episode schizophrenia, and to examine relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Chuanjun, Hu, Shuiqing, Chen, Guangdong, Yang, Lei, Cai, Ziyao, Tian, Hongjun, Jiang, Deguo, Chen, Chunmian, Wang, Lina, Ma, Xiaoyan, Li, Ranli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576794/
https://www.ncbi.nlm.nih.gov/pubmed/37838729
http://dx.doi.org/10.1038/s41537-023-00400-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576794/
https://www.ncbi.nlm.nih.gov/pubmed/37838729
http://dx.doi.org/10.1038/s41537-023-00400-w

Ejemplares similares